Seed Investments

Building and investing in biotech from seed to success

What we do

We drive innovation in life sciences by identifying, building, and investing in transformative biotech startups. Leveraging the capabilities of our in-house SeedLab and our robust network of Entrepreneurs-in-Residence (EiRs), we focus on creating and nurturing companies to transform promising science into impactful therapeutic focused biotech companies.

For more insights and the stories behind our portfolio, visit our 'de novo' blog.

Søren Møller,

“Through our hands-on approach, we ensure that promising projects and startup companies have the optimal conditions for success.”

Søren Møller,

Managing Partner, Seed Investments

Strategy - From startup to exit

We provide capital, network and know-how to transform promising life-science discoveries into successful biotech startups.

We focus on company creation and building biotech startups in the Nordic region. Seed Investments aims to develop strong and competitive companies that we finance all the way to a commercial exit.

By the end of 2024, Seeds Investments’ portfolio comprised of 35 companies. Most of the portfolio consists of private investments, valued at DKK 4.2 billion at year end, 19% higher than at the end of 2023. 

Seed Investments key figures

DKK4.2 bn

Value of Investments Assets portfolio by the end of 2024

35

Number of portfolio companies

200m

Deployed in 2023

See Annual Report

Our Seed Investments Portfolio

Search

Meet our team

Seed Investments is comprised of a team of investment professionals that are dedicated to working with scientists and entrepreneurs to build successful biotech companies.

Latest Seed Investments' news and reports